Antonio Urbano, data integration specialist at Aon, tells us why the right team makes for countless opportunities and Dublin’s nightlife ticks all the right boxes.
Dublin: 03.03.2015 08.56AM
Aspen is to create 44 jobs in Citywest, Dublin, as the generic pharmaceutical company is establishing a global regulatory, pharmacovigilance, quality assurance and supply projects centre of excellence.
The new jobs will bring Aspen’s total workforce in Ireland to 58.
Ireland’s Minister for Jobs, Enterprise and Innovation, Richard Bruton, TD, who announced the new jobs today, said pharmaceuticals are a major sector of strength for Ireland, with nine out of the top 10 global companies located in the country.
“However a key part of the Government’s plan for jobs and growth is targeting the areas of growth within what is a changing sector – in particular, generics. Today’s announcement that Aspen, one of the world’s leading generic pharmaceutical companies is expanding its operations here is very welcome news. I am determined to ensure that we build on this to target further generics investments to create the jobs and growth we need,” Bruton said.
Stephen Saad, group chief executive of Aspen, said Ireland provides Aspen with a workforce with the specialised skills it requires and a strong regulatory and business environment.
“I would like to thank the Irish Government and IDA Ireland for their support and look forward to the future development of Aspen in Ireland,” Saad said.
Aspen first set up shop in Ireland in 2012, and that operation has now become Aspen’s European marketing and supply chain headquarters.
Barry O’Leary, CEO of IDA Ireland, said Aspen’s decision to locate its operation in Ireland adds to the country’s cluster of life sciences companies, and will add to Ireland’s reputation as a leading centre of for this sector.
In addition to being one of the largest generic global pharmaceutical companies, Aspen is also the largest producer of anti-retroviral (HIV) drugs in South Africa.
“Ireland offers South Africa’s largest pharmaceutical company a strategic location from which to support its ongoing expansion and grow its sales across Europe,” said O’Leary.